BTG is focused on bringing to market innovative products in specialist areas of medicine to better serve doctors and patients. BTG's Interventional Medicine therapies are designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins, whilst the company's Pharmaceuticals portfolio offers antidotes that alleviate toxicity and treat rare conditions.
Inspired by a deep understanding of their customers’ needs, BTG is working to meaningfully improve the lives of patients and their healthcare experience. BTG identify their competitive advantage as their dedication to finding smart, often unconventional solutions to complex medical problems. Many BTG products combine medicines, device technology, and new techniques in order to deliver more targeted treatments.